A Preview Of Journey Medical's Earnings
Portfolio Pulse from Benzinga Insights
Journey Medical (NASDAQ:DERM) is set to release its latest quarterly earnings report on November 7, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's past performance shows a pattern of beating EPS estimates, which has often resulted in an increase in share price. The company's shares are currently trading at $3.45 and have seen a 40.87% increase over the last 52-week period.
November 06, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Journey Medical's upcoming earnings report could potentially impact its stock price. The company has a history of beating EPS estimates, which has often led to an increase in its share price.
The company's earnings report is a significant event that could potentially impact its stock price. Given the company's history of beating EPS estimates, there is a possibility that it could do so again, which could lead to an increase in its share price. However, it's also important to note that other factors, such as the company's guidance, could also impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100